Home › Funds › BIT Capital GmbH › DFTX
BIT Capital GmbH position in DFTX
DEFINIUM THERAPEUTICS INC · Health Care
BIT Capital GmbH reported holding 83,460 shares of DFTX (DEFINIUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.2M, representing 0.15% of its reported portfolio and ranking #40 among its reported holdings. BIT Capital GmbH has disclosed DFTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How BIT Capital GmbH's DFTX position evolved
BIT Capital GmbH first disclosed a stake in DFTX in Q1 2026 at 277,511 shares (US$5.2M). The position peaked in Q2 2026 at 128,131 shares, worth US$6.0M. Across 3 filings, BIT Capital GmbH increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 83,460 shares valued at US$3.2M — a reduction of -44,671 shares quarter over quarter.. Notable position changes include a 54% trim in Q2 2026 (shares fell 19% over the following quarter), a 35% trim in Q3 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 277.51K | $5.24M | New |
| Q2 2026 | 128.13K | $6.03M | Reduce |
| Q3 2026 | 83.46K | $3.18M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DFTX and 13F data
DFTX (DEFINIUM THERAPEUTICS INC) is a Health Care company. 158 other funds we track also report a position in DFTX — the largest reported positions include Avoro Capital Advisors LLC (US$338.2M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$322.0M), Octagon Capital Advisors LP (US$138.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DFTX
- Avoro Capital Advisors LLC 7.19M sh · $338.17M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 6.85M sh · $322.00M · Q2 2026
- Octagon Capital Advisors LP 2.95M sh · $138.77M · Q2 2026
- Deep Track Capital, LP 2.75M sh · $129.36M · Q2 2026
- Commodore Capital LP 2.00M sh · $94.08M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.50M sh · $70.56M · Q2 2026
- Boxer Capital Management, LLC 998.50K sh · $46.97M · Q2 2026
- AWM Investment Company, Inc. 784.80K sh · $36.92M · Q2 2026
- ArrowMark Colorado Holdings LLC 564.07K sh · $26.53M · Q2 2026
- Catalio Capital Management, LP 562.67K sh · $26.47M · Q2 2026
- Integral Health Asset Management, LLC 550.00K sh · $25.87M · Q2 2026
- GREAT POINT PARTNERS LLC 425.00K sh · $19.99M · Q2 2026
More on BIT Capital GmbH
FAQ
How long has BIT Capital GmbH held DFTX?
BIT Capital GmbH has disclosed DFTX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is BIT Capital GmbH's current position in DFTX?
As of Q3 2026, BIT Capital GmbH holds 83.46K shares of DFTX (DEFINIUM THERAPEUTICS INC), valued at $3.18M, representing 0.15% of its reported portfolio and ranking #40.
Has BIT Capital GmbH been buying or selling DFTX?
In the latest 13F filing (Q3 2026), BIT Capital GmbH reduced its position in DFTX. The position peaked in Q2 2026 at 128.13K shares.
Which other funds hold DFTX?
Other major institutional holders of DFTX include Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Octagon Capital Advisors LP, among 158 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.